Efficacy and safety of the combination of reduced duration prophylaxis followed by immuno-guided prophylaxis to prevent cytomegalovirus disease in lung transplant recipients (CYTOCOR STUDY) : An open-label, randomised, non-inferiority clinical trial - Páez-Vega, Aurora (Spanish Network for Research in Infectious Diseases) ; Cantisan, Sara (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ; Vaquero, José Manuel (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ; Vidal, Elisa (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ; Luque-Pineda, Antonio (Instituto Maimónides de Investigación Biomédica de Córdoba) ; Lobo-Acosta, María Ángeles (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Pérez, Ana Belén (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ; Alonso-Moralejo, Rodrigo (Hospital Universitario 12 de Octubre (Madrid)) ; Iturbe, David (Instituto de Investigación Sanitaria Valdecilla (Santander, Cantàbria)) ; Monforte, Víctor (Hospital Universitari Vall d'Hebron) ; Otero-González, Isabel (Instituto de Investigación Biomédica de A Coruña) ; Pastor, Amparo (Hospital Universitari i Politècnic La Fe (València)) ; Ussetti, Piedad (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Torre-Cisneros, Julian (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ; Universitat Autònoma de Barcelona
 
Comments (0) | Reviews (0)
Be the first to review this document.

Add review

Rate this article:
Give a title to your review:
Write your review:
Note: you have not defined your nickname.
N/D will be displayed as the author of this comment.